PubMed

NIH conference. Alzheimer disease: clinical and biological heterogeneity.

Friedland RP, Koss E, Haxby JV, Grady CL, Luxenberg J, Schapiro MB, Kaye J.

Ann Intern Med. 1988 Aug 15;109(4):298-311. Review.PMID: 2969203 [PubMed - indexed for MEDLINE]Related articles

[Heterogeneity of Alzheimer's disease]

Scheltens P, Vermersch P, Leys D.

Rev Neurol (Paris). 1993;149(1):14-25. Review. French. PMID: 8337557 [PubMed - indexed for MEDLINE]Related articles

[Clinical heterogeneity of Alzheimer's disease. Different clinical profiles can predict the progression rate]

Mangone CA.

Rev Neurol. 2004 Apr 1-15;38(7):675-81. Review. Spanish. PMID: 15098191 [PubMed - indexed for MEDLINE]Related articlesFree article

Cognitive and anatomic contributions of metabolic decline in Alzheimer disease and cerebrovascular disease.

Kuczynski B, Reed B, Mungas D, Weiner M, Chui HC, Jagust W.

Arch Neurol. 2008 May;65(5):650-5.PMID: 18474742 [PubMed - indexed for MEDLINE]Related articlesFree article

Perceived loss of memory ability and cerebral metabolic decline in persons with the apolipoprotein E-IV genetic risk for Alzheimer disease.

Ercoli L, Siddarth P, Huang SC, Miller K, Bookheimer SY, Wright BC, Phelps ME, Small G.

Arch Gen Psychiatry. 2006 Apr;63(4):442-8.PMID: 16585474 [PubMed - indexed for MEDLINE]Related articlesFree article

Features of regional cerebral glucose metabolism abnormality in corticobasal degeneration.

Hirono N, Ishii K, Sasaki M, Kitagaki H, Hashimoto M, Imamura T, Tanimukai S, Hanihara T, Kazui H, Mori E.

Dement Geriatr Cogn Disord. 2000 May-Jun;11(3):139-46.PMID: 10765044 [PubMed - indexed for MEDLINE]Related articles

Alzheimer's disease: metabolic uncoupling of associative brain regions.

Rapoport SI, Horwitz B, Haxby JV, Grady CL.

Can J Neurol Sci. 1986 Nov;13(4 Suppl):540-5.PMID: 3491664 [PubMed - indexed for MEDLINE]Related articles

Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.

Pietrini P, Dani A, Furey ML, Alexander GE, Freo U, Grady CL, Mentis MJ, Mangot D, Simon EW, Horwitz B, Haxby JV, Schapiro MB.

Am J Psychiatry. 1997 Aug;154(8):1063-9.PMID: 9247390 [PubMed - indexed for MEDLINE]Related articles

Difference of regional cerebral metabolic pattern between presenile and senile dementia of the Alzheimer type: a factor analytic study.

Ichimiya A, Herholz K, Mielke R, Kessler J, Slansky I, Heiss WD.

J Neurol Sci. 1994 May;123(1-2):11-7.PMID: 8064302 [PubMed - indexed for MEDLINE]Related articles

Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.

Alexander GE, Chen K, Pietrini P, Rapoport SI, Reiman EM.

Am J Psychiatry. 2002 May;159(5):738-45.PMID: 11986126 [PubMed - indexed for MEDLINE]Related articlesFree article

Regional cerebral glucose metabolism in children with deterioration of one or more cognitive functions and continuous spike-and-wave discharges during sleep.

Maquet P, Hirsch E, Metz-Lutz MN, Motte J, Dive D, Marescaux C, Franck G.

Brain. 1995 Dec;118 ( Pt 6):1497-520.PMID: 8595480 [PubMed - indexed for MEDLINE]Related articles

Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.

Drzezga A, Lautenschlager N, Siebner H, Riemenschneider M, Willoch F, Minoshima S, Schwaiger M, Kurz A.

Eur J Nucl Med Mol Imaging. 2003 Aug;30(8):1104-13. Epub 2003 May 23.PMID: 12764551 [PubMed - indexed for MEDLINE]Related articles

Metabolic patterns associated with the clinical response to galantamine therapy: a fludeoxyglucose f 18 positron emission tomographic study.

Mega MS, Dinov ID, Porter V, Chow G, Reback E, Davoodi P, O'Connor SM, Carter MF, Amezcua H, Cummings JL.

Arch Neurol. 2005 May;62(5):721-8.PMID: 15883258 [PubMed - indexed for MEDLINE]Related articlesFree article

The neurometabolic landscape of cognitive decline: in vivo studies with positron emission tomography in Alzheimer's disease.

Pietrini P, Alexander GE, Furey ML, Hampel H, Guazzelli M.

Int J Psychophysiol. 2000 Jul;37(1):87-98. Review.PMID: 10828377 [PubMed - indexed for MEDLINE]Related articles

Association of elevated phospho-tau levels with Alzheimer-typical 18F-fluoro-2-deoxy-D-glucose positron emission tomography findings in patients with mild cognitive impairment.

Fellgiebel A, Siessmeier T, Scheurich A, Winterer G, Bartenstein P, Schmidt LG, Müller MJ.

Biol Psychiatry. 2004 Aug 15;56(4):279-83.PMID: 15312816 [PubMed - indexed for MEDLINE]Related articles

Abnormalities of regional brain metabolism in Alzheimer's disease and their relation to functional impairment.

Haxby JV, Rapoport SI.

Prog Neuropsychopharmacol Biol Psychiatry. 1986;10(3-5):427-38. Review.PMID: 3541045 [PubMed - indexed for MEDLINE]Related articles

Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease.

Anchisi D, Borroni B, Franceschi M, Kerrouche N, Kalbe E, Beuthien-Beumann B, Cappa S, Lenz O, Ludecke S, Marcone A, Mielke R, Ortelli P, Padovani A, Pelati O, Pupi A, Scarpini E, Weisenbach S, Herholz K, Salmon E, Holthoff V, Sorbi S, Fazio F, Perani D.

Arch Neurol. 2005 Nov;62(11):1728-33.PMID: 16286547 [PubMed - indexed for MEDLINE]Related articlesFree article

Brain-imaging surrogate markers for detection and prevention of age-related memory loss.

Small GW.

J Mol Neurosci. 2002 Aug-Oct;19(1-2):17-21. Review.PMID: 12212776 [PubMed - indexed for MEDLINE]Related articles

Early diagnosis of Alzheimer disease with positron emission tomography.

Jelic V, Nordberg A.

Alzheimer Dis Assoc Disord. 2000;14 Suppl 1:S109-13. Review.PMID: 10850738 [PubMed - indexed for MEDLINE]Related articles

Differences in lateral hemispheric asymmetries of glucose utilization between early- and late-onset Alzheimer-type dementia.

Koss E, Friedland RP, Ober BA, Jagust WJ.

Am J Psychiatry. 1985 May;142(5):638-40.PMID: 3872604 [PubMed - indexed for MEDLINE]Related articles